Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Elizabeth Shay, Ahmad Kheirkhah, Lingyi Liang, Hossam Sheha, Darren G. Gregory, Scheffer C.G. Tseng

Producción científica: Articlerevisión exhaustiva

84 Citas (Scopus)

Resumen

Stevens-Johnson syndrome and its more severe variant, toxic epidermal necrolysis, have relatively low overall incidence; however, this disease presents with high morbidity and mortality. The majority of patients develop ocular inflammation and ulceration at the acute stage. Due to the hidden nature of these ocular lesions and the concentration of effort toward life-threatening issues, current acute management has not devised a strategy to preclude blinding cicatricial complications. This review summarizes recent literature data, showing how sight-threatening corneal complications can progressively develop from cicatricial pathologies of lid margin, tarsus, and fornix at the chronic stage. It illustrates how such pathologies can be prevented with the early intervention of cryopreserved amniotic membrane transplantation to suppress inflammation and promote epithelial healing at the acute stage. Significant dry eye problems and photophobia can also be avoided with this intervention. This new therapeutic strategy can avert the catastrophic ophthalmic sequelae of this rare but devastating disease.

Idioma originalEnglish (US)
Páginas (desde-hasta)686-696
Número de páginas11
PublicaciónSurvey of Ophthalmology
Volumen54
N.º6
DOI
EstadoPublished - nov 2009
Publicado de forma externa

ASJC Scopus subject areas

  • Ophthalmology

Huella

Profundice en los temas de investigación de 'Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis'. En conjunto forman una huella única.

Citar esto